FDA clears Watson generic of Wellbutrin XL antidepressant

06/13/2007 | Forbes

Watson Pharmaceuticals says it has won FDA approval for its generic of Wellbutrin XL, the antidepressant made by Biovail Corp. and sold by GlaxoSmithKline. Watson said it plans to market its extended-release version immediately.

View Full Article in:

Forbes

Published in Brief:

SmartBrief Job Listings for Health Care